Company Analysis

QuidelOrtho Corporation (QDEL)

Nasdaq: QDEL · In Vitro & In Vivo Diagnostic Substances · San Diego, CA · filing with the SEC since 2022
Grade4.8
◀ Past 5.8● Present 5.0▶ Future 3.6

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

305 patents granted to the 13 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to QuidelOrtho Corporation’s names, not what it holds today.

Patents granted
305
303 utility, 2 design, 1976 to Dec 31, 2025
Granted in 2025
6
Against 9 in 2024 and 9 in 2023
Applications published
245
6 of them in 2025
Names they are printed under
13
a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Analysis of biological materials21
Measurement6
Computer technology4
Chemical engineering3
Biotechnology3
Medical technology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name13 counted
Ortho-Clinical Diagnostics, Inc. a subsidiary
US, as the owner printed on each patent
173 granted
57 published
QUIDEL CORPORATION a subsidiary
US, as the owner printed on each patent
87 granted
37 published
Ortho-Clinical Diagnostics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
72 published
Diagnostic Hybrids, Inc. a subsidiary
US, as the owner printed on each patent. 2 more under the same name are not counted (printed in GR)
33 granted
19 published
Quidel Corporation a subsidiary
named as the applicant on its applications, in US
0 granted
47 published
BIO-HELIX CO., LTD. a subsidiary
US, as the owner printed on each patent. 2 more under the same name are not counted (printed in TW)
3 granted
3 published
QUIDEL CARDIOVASCULAR INC. a subsidiary
US, as the owner printed on each patent
4 granted
2 published
Quidel Cardiovascular Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
4 published
Immutopics, Inc. a subsidiary
US, as the owner printed on each patent
3 granted
0 published
Diagnostic Hybrids, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
2 published
Micro Typing Systems, Inc. a subsidiary
US, as the owner printed on each patent
2 granted
0 published
BioHelix Corporation a subsidiary
named as the applicant on its applications, in US. 2 more under the same name are not counted (printed in TW)
0 granted
1 published
QUIDEL CORPORATION, a Delaware corporation a subsidiary
US, as the owner printed on each patent
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 18, 202512,474,333Interactive test system and method for detecting an analyteAnalysis of biological materialsOrtho-Clinical Diagnostics, Inc.
Jul 1, 202512,345,700Device for whole blood separationChemical engineeringOrtho-Clinical Diagnostics, Inc.
Jun 24, 202512,339,280N-acetyl-D-glucosamine for enhanced specificity of strep a immunoassayAnalysis of biological materialsOrtho-Clinical Diagnostics, Inc.
May 13, 202512,298,251System and methods for remote assessment of a sample assay for disease diagnosticsMeasurementOrtho-Clinical Diagnostics, Inc.
May 6, 202512,290,806Substrate with channels for controlled fluid flowAnalysis of biological materialsOrtho-Clinical Diagnostics, Inc.
Apr 29, 202512,285,755Lateral-flow assay device with filtration flow controlAnalysis of biological materialsOrtho-Clinical Diagnostics, Inc.
Dec 24, 202412,174,185Compositions and methods for detecting autoantibodiesAnalysis of biological materialsQUIDEL CORPORATION
Dec 10, 202412,165,373Software and algorithms for use in remote assessment of disease diagnosticsComputer technologyOrtho-Clinical Diagnostics, Inc.
Oct 22, 202412,123,875Antigen analogue for calibration of immunometric diagnostic assaysBiotechnologyOrtho-Clinical Diagnostics, Inc.
Oct 15, 202412,117,443Immunoassay controls and the use thereofAnalysis of biological materialsQUIDEL CARDIOVASCULAR INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 11, 20252025/0378954SYSTEM FOR VISUALIZING AND SUPPORTING A CONTEXTUAL DIAGNOSTIC DECISION FOR CONTAGIOUS DISEASESMedical technologyQuidel Corporation
Oct 30, 20252025/0334573LATERAL FLOW IMMUNOASSAYS COMPRISING FLUIDIC CHANNELSAnalysis of biological materialsOrtho-Clinical Diagnostics, Inc.
Jul 31, 20252025/0246319SYSTEM FOR COLLECTING AND DISPLAYING DIAGNOSTICS FROM DIAGNOSTIC INSTRUMENTSComputer technologyOrtho-Clinical Diagnostics, Inc.
Jul 24, 20252025/0237613SYSTEM AND METHODS FOR REMOTE ASSESSMENT OF A SAMPLE ASSAY FOR DISEASE DIAGNOSTICSMeasurementOrtho-Clinical Diagnostics, Inc.
Jul 24, 20252025/0235860SUBSTRATE WITH CHANNELS FOR CONTROLLED FLUID FLOWAnalysis of biological materialsOrtho-Clinical Diagnostics, Inc.
Feb 27, 20252025/0069353SOFTWARE AND ALGORITHMS FOR USE IN REMOTE ASSESSMENT OF DISEASE DIAGNOSTICSComputer technologyOrtho-Clinical Diagnostics, Inc.
Nov 14, 20242024/0377395AGGLUTINATING AGENTS, DEVICES AND METHODS FOR WHOLE BLOOD ASSAYSAnalysis of biological materialsQuidel Corporation
Sep 19, 20242024/0310362METHOD TO IDENTIFY INDIVIDUALS WITH T CELL IMMUNITY TO SPECIFIC INFECTIOUS AGENTSMeasurementQuidel Corporation
Jul 18, 20242024/0241025IMAGE CAPTURING AND PROCESSING FOR IMMUNOASSAYSMeasurementQuidel Corporation
Jul 11, 20242024/0230639DEVICES AND KITS FOR DETECTING ANALYTES OF INTEREST AND METHODS OF USING THE SAMEMeasurementQuidel Corporation
What it applied for, 2024 to 2025: Analysis of biological materials 8 · Measurement 6 · Computer technology 2 · Biotechnology 1 · Medical technology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton QDEL · research, not advice